Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 7-14, April 2007

Aristolochic Acid Nephropathy: The Hong Kong Perspective

  • Wing-Tat Poon
    • ,
  • Chi-Kong Lai
    • ,
  • Albert Yan-Wo Chan

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to: Dr. Albert Y.W. Chan, Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong SAR, China. Fax: (+852) 2370-0969

Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong SAR, China

Article Outline

Aristolochic acid nephropathy (AAN) is a progressive tubulointerstitial nephropathy attributed to aristolochic acid (AA) toxicity. Five cases of AAN have been diagnosed in Hong Kong. Most were caused by the inadvertent substitution of innocuous herbs with Aristolochia species. Our findings contributed to the withdrawal of the AA-containing herbs and products in Hong Kong. This paper aims to review the topic of AAN from a Hong Kong perspective.

Key words:  aristolochic acid , Chinese medicine , herbs , nephropathy

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Peters G , Hedwall PR . Aristolochic acid intoxication: a new type of impairment of urinary concentrating ability . Arch Int Pharmacodyn Ther . 1963;145:334–355
  2. Wu SH . Two cases of acute renal failure caused by Mutong . Jiang Xi Zhong Yi . 1964;10:12–14 [In Chinese]
  3. Hong YS , Huang YL , Wang YJ . Over-dose of Mutong causes renal failure and death . Zhe Jiang Zhong Yi Za Zhi . 1965;8:32; [In Chinese]
  4. Zhou FJ , Lu HW , Nie CF . Toxicity of Mutong causes acute renal failure . Zhonghua Shenzanbing Za Zhi . 1988;4:223–224 [In Chinese]
  5. Ma H , Cheung P . Literature review of MuTong related adverse events . In: Guanmutong Shenduxing Yanjiu . Beijing: Chemical Industry Press; 2005;p. 1–64 [In Chinese]
  6. Tsui L . Review of the widespread toxicity caused by Aristolochiae Fangchi and Manshuriensis . Chinese Traditional and Herbal Drugs . 2001;32:88–89 [In Chinese]
  7. van Ypersele de Strihou C , Vanherweghem JL . The tragic paradigm of Chinese herbs nephropathy . Nephrol Dial Transplant . 1995;10:157–160
  8. Vanherweghem JL , Depierreux M , Tielemans C , Abramowicz D , Dratwa M , Jadoul M , et al.   Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs . Lancet . 1993;341:387–391
  9. Nortier JL , Martinez MCM , Schmeiser HH , Arlt VM , Bieler CA , Petein M , et al.   Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . N Engl J Med . 2000;342:1686–1692
  10. But PP . Need for correct identification of herbs in herbal poisoning . Lancet . 1993;341:637
  11. Vanhaelen M , Vanhaelen-Fastre R , But P , Vanherweghem JL . Identification of aristolochic acid in Chinese herbs . Lancet . 1994;343:174
  12. Schmeiser HH , Bieler CA , Wiessler M , van Ypersele de Strihou C , Cosyns JP . Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy . Cancer Res . 1996;56:2025–2028
  13. Mengs U , Lang W , Poch JA . The carcinogenic action of aristolochic acid in rats . Arch Toxicol . 1982;51:107–119
  14. Bieler CA , Stiborova M , Wiessler M , Cosyns JP , van Ypersele de Strihou C , Schmeiser HH . 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy . Carcinogenesis . 1997;18:1063–1067
  15. Cosyns JP , Dehoux JP , Guiot Y , Goebbels RM , Robert A , Bernard AM , et al.   Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? . Kidney Int . 2001;59:2164–2173
  16. Chen HY , Ma BY , Grant A , Lampert N . Time to abandon the term “Chinese herbs nephropathy” . Kidney Int . 2001;60:2039–2040
  17. Pourrat J , Montastruc JL , Lacombe JL , Cisterne JM , Rascol O , Dumazer P . Nephropathy associated with Chinese herbal drugs. 2 cases . Presse Med . 1994;23:1669; [In French]
  18. Pena JM , Borras M , Ramos J , Montoliu J . Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion . Nephrol Dial Transplant . 1996;11:1359–1360
  19. Lord GM , Tagore R , Cook T , Gower P , Pusey CD . Nephropathy caused by Chinese herbs in the UK . Lancet . 1999;354:481–482
  20. Meyer MM , Chen TP , Bennett WM . Chinese herb nephropathy . BUMC Proc . 2000;13:334–337
  21. Schwetz BA . From the Food and Drug Administration . JAMA . 2001;285:2705
  22. Kessler DA . Cancer and herbs . N Engl J Med . 2000;342:1742–1743
  23. Kumar V , Poonam  , Prasad AK , Parmar VS . Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities . Nat Prod Rep . 2003;20:565–583
  24. The State Pharmacopoeia Commission of P.R. China  . In: Pharmacopoeia of the People's Republic of China . Vol. 1: Beijing: Chemical Industry Press; 2000;
  25. Chan W , Hui KM , Poon WT , Lee KC , Cai Z . Differentiation of herbs linked to “Chinese herb nephropathy” from the liquid chromatographic determination of aristolochic acids . Anal Chim Acta . 2006;576:112–116
  26. Jong TT , Lee MR , Hsiao SS , Hsai JL , Wu TS , Chiang ST , et al.   Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry . J Pharm Biomed Anal . 2003;33:831–837
  27. Mengs U . Acute toxicity of aristolochic acid in rodents . Arch Toxicol . 1987;59:328–331
  28. Mengs U , Stotzem CD . Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology . Arch Toxicol . 1993;67:307–311
  29. Arlt VM , Schmeiser HH , Pfeifer GP . Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR . Carcinogenesis . 2001;22:133–140
  30. Robisch G , Schimmer O , Goggelmann W . Aristolochic acid is a direct mutagen in Salmonella typhimurium . Mutat Res . 1982;105:201–204
  31. Zhang H , Cifone MA , Murli H , Erexson GL , Mecchi MS , Lawlor TE . Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid . Food Chem Toxicol . 2004;42:2021–2028
  32. Mengs U . Tumour induction in mice following exposure to aristolochic acid . Arch Toxicol . 1988;61:504–505
  33. Lord GM , Cook T , Arlt VM , Schmeiser HH , Williams G , Pusey CD . Urothelial malignant disease and Chinese herbal nephropathy . Lancet . 2001;358:1515–1516
  34. Balachandran P , Wei F , Lin RC , Khan IA , Pasco DS . Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells . Kidney Int . 2005;67:1797–1805
  35. Depierreux M , Van Damme B , Vanden Houte K , Vanherweghem JL . Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs . Am J Kidney Dis . 1994;24:172–180
  36. Wojcikowski K , Johnson DW , Gobe G . Medicinal herbal extracts—renal friend or foe? Part one: the toxicities of medicinal herbs . Nephrology (Carlton) . 2004;9:313–318
  37. Hong YT , Fu LS , Chung LH , Hung SC , Huang YT , Chi CS . Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs . Pediatr Nephrol . 2006;21:577–579
  38. Nortier JL , Schmeiser HH , Muniz Martinez MC , Arlt VM , Vervaet C , Garbar CH , et al.   Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure . Nephrol Dial Transplant . 2003;18:426–428
  39. Cosyns JP , Jadoul M , Squifflet JP , Wese FX , van Ypersele de Strihou C . Urothelial lesions in Chinese-herb nephropathy . Am J Kidney Dis . 1999;33:1011–1017
  40. Martinez MC , Nortier J , Vereerstraeten P , Vanherweghem JL . Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose . Nephrol Dial Transplant . 2002;17:408–412
  41. Li H , Liu Z , Chen H , Zhu M , Li L . Ultrastructural changes of human proximal tubular epithelial cells incubated with aristolochic acid I . Shenzanbing Yu Toxi Shenyizhi Za Zhi . 2001;10:242–246 [In Chinese]
  42. Lebeau C , Debelle FD , Arlt VM , Pozdzik A , De Prez EG , Phillips DH , et al.   Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies . Nephrol Dial Transplant . 2005;20:2321–2332
  43. Hsin YH , Cheng CH , Tzen JT , Wu MJ , Shu KH , Chen HC . Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells . Apoptosis . 2006;11:2167–2177
  44. Li X , Wang H . Aristolochic acid nephropathy: what we know and what we have to do . Nephrology (Carlton) . 2004;9:109–111
  45. Sun D , Feng J , Dai C , Sun L , Jin T , Ma J , et al.   Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy . Am J Nephrol . 2006;26:363–371
  46. In:  Gold LS ,  Zeiger E editor. Handbook of Carcinogenic Potency and Genotoxicity Databases . Boca Raton, FL: CRC Press; 1997;
  47. Arlt VM , Wiessler M , Schmeiser HH . Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene . Carcinogenesis . 2000;21:235–242
  48. Stiborova M , Frei E , Breuer A , Wiessler M , Schmeiser HH . Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase — (32)P-postlabeling analysis of DNA adduct formation . Mutat Res . 2001;493:149–160
  49. Arlt VM , Stiborova M , Schmeiser HH . Aristolochic acid as a probable human cancer hazard in herbal remedies: a review . Mutagenesis . 2002;17:265–277
  50. Pfau W , Schmeiser HH , Wiessler M . Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA . Carcinogenesis . 1990;11:313–319
  51. Feldmeyer N , Schmeiser HH , Muehlbauer KR , Belharazem D , Knyazev Y , Nedelko T , et al.   Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences . Mutat Res . 2006;608:163–168
  52. Broschard TH , Wiessler M , von der Lieth CW , Schmeiser HH . Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid . Carcinogenesis . 1994;15:2331–2340
  53. Lord GM , Hollstein M , Arlt VM , Roufosse C , Pusey CD , Cook T , et al.   DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy . Am J Kidney Dis . 2004;43:e11–e17
  54. Vanherweghem LJ . Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) . J Altern Complement Med . 1998;4:9–13
  55. De Broe ME . On a nephrotoxic and carcinogenic slimming regimen . Am J Kidney Dis . 1999;33:1171–1173
  56. Kanaan N , Cosyns JP , Jadoul M , Goffin E . The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency . Nephrol Dial Transplant . 2003;18:440–442
  57. Olsen S . Histopathology of drug and toxin induced kidney lesions . Zentralbl Allg Pathol . 1986;132:365–383
  58. Reginster F , Jadoul M , van Ypersele de Strihou C . Chinese herbs nephropathy presentation, natural history and fate after transplantation . Nephrol Dial Transplant . 1997;12:81–86
  59. Yang CS , Lin CH , Chang SH , Hsu HC . Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs . Am J Kidney Dis . 2000;35:313–318
  60. Vanherweghem JL , Abramowicz D , Tielemans C , Depierreux M . Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy . Am J Kidney Dis . 1996;27:209–215
  61. Zhu S , Liu J , Chen L , Li Y , Yao J , Jin C , et al.   Chemopreventive effect of five drugs on renal interstitial fibrosis induced by an aristolochic acid-containing Chinese herb in rats . Am J Nephrol . 2005;25:23–29
  62. Tanaka A , Nishida R , Maeda K , Sugawara A , Kuwahara T . Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? . Clin Nephrol . 2000;53:301–306
  63. Yang SS , Chu P , Lin YF , Chen A , Lin SH . Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis . Am J Kidney Dis . 2002;39:E14
  64. Tanaka A , Nishida R , Yoshida T , Koshikawa M , Goto M , Kuwahara T . Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium? . Intern Med . 2001;40:296–300
  65. Yu Y , Zheng FL , Li H . Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases . Zhonghua Nei Ke Za Zhi . 2003;42:110–112 [In Chinese]
  66. Lee S , Lee T , Lee B , Choi H , Yang M , Ihm CG , et al.   Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid . Nephrology . 2004;9:126–129
  67. Krumme B , Endmeir R , Vanhaelen M , Walb D . Reversible Fanconi syndrome after ingestion of a Chinese herbal ‘remedy’ containing aristolochic acid . Nephrol Dial Transplant . 2001;16:400–402
  68. Izumotani T , Ishimura E , Tsumura K , Goto K , Nishizawa Y , Morii H . An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs . Nephron . 1993;65:137–140
  69. Tanaka A , Nishida R , Yokoi H , Kuwahara T . The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome: could iminoaciduria be the hallmark of this syndrome? . Clin Nephrol . 2000;54:198–202
  70. Tsai CS , Chen YC , Chen HH , Cheng CJ , Lin SH . An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome . Am J Med Sci . 2005;330:153–155
  71. Gillerot G , Jadoul M , Arlt VM , van Ypersele De Strihou C , Schmeiser HH , But PP , et al.   Aristolochic acid nephropathy in a Chinese patient: time to abandon the term “Chinese herbs nephropathy”? . Am J Kidney Dis . 2001;38:E26
  72. Li X , Yang L , Yu Y . An analysis of the clinical and pathological characteristics of mu-tong (a Chinese herb) induced tubulointerstitial nephropathy . Zhonghua Nei Ke Za Zhi . 2001;40:681–687 [In Chinese]
  73. Chen W , Chen Y , Li A . The clinical and pathological manifestations of aristolochic acid nephropathy—the report of 58 cases . Zhonghua Yi Xue Za Zhi . 2001;81:1101–1105 [In Chinese]
  74. Ng ML, Deng JF. The debate about use of aristolochic acid-containing herb drugs. In: Workshop on Herbal Medicine Poisonings. Taiwan, 2003.
  75. Laing C , Hamour S , Sheaff M , Miller R , Woolfson R . Chinese herbal uropathy and nephropathy . Lancet . 2006;368:338
  76. Lo SHK , Mo KL , Wong KS , Poon SP , Chan CK , Lai CK , et al.   Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis . Nephrol Dial Transplant . 2004;19:1913–1915
  77. Lo SH , Wong KS , Arlt VM , Phillips DH , Lai CK , Poon WT , et al.   Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy . Am J Kidney Dis . 2005;45:407–410
  78. Arlt VM , Alunni-Perret V , Quatrehomme G , Ohayon P , Albano L , Gaid H , et al.   Aristolochic acid (AA)-DNA adduct as markerof AA exposure and risk factor for AA nephropathy-associated cancer . Int J Cancer . 2004;111:977–980
  79. Ma H , Cheung P . The safety of aristolochic herbs . In: Guanmutong Shenduxing Yanjiu . Beijing: Chemical Industry Press; 2005;p. 279–360 [In Chinese]
  80. Hong Kong Department of Health  . Updated Control Measures for Medicinal Herbs Announced . Hong Kong: Hong Kong Department of Health; 2004;
  81. Jong TT , Lee MR , Hsiao SS , Hsai JL , Wu TS , Chiang ST , et al.   Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry . J Pharm Biomed Anal . 2003;33:831–837
  82. Li K . Analysis of aristolochic acid A in root of Herba Asari by Rp– HPLC . LiaoNing Zhong Yi Za Zhi . 2005;32:1080–1081 [In Chinese]
  83. Yang HY , Lin JL , Chen KH , Yu CC , Hsu PY , Lin CL . Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin . J Nephrol . 2006;19:111–114
  84. Cheung TP , Xue C , Leung K , Chan K , Li CG . Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products—a consequence of inappropriate nomenclature and imprecise labelling? . Clin Toxicol (Phila) . 2006;44:371–378
  85. Gold LS , Slone TH . Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert . N Engl J Med . 2003;349:1576–1577
  86. Schaneberg BT , Khan IA . Analysis of products suspected of containing Aristolochia or Asarum species . J Ethnopharmacol . 2004;94:245–249
  87. Ioset JR , Raoelison GE , Hostettmann K . Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens . Food Chem Toxicol . 2003;41:29–36
  88. Ye ZB , Xu J , Mei XB . Influence of long-term use of low dose caulis Aristolochiae manshuriensis on partial nephrectomized rats . Zhongguo Zhong Xi Yi Jie He Za Zhi . 2002;22:447–449 [In Chinese]
  89. Cheng CL , Chen KJ , Shih PH , Lu LY , Hung CF , Lin WC , et al.   Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents . Cancer Lett . 2006;232:236–242
  90. Chan TY , Tam HP , Lai CK , Chan AY . A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines . Ther Drug Monit . 2005;27:53–57
  91. Ma HM , Zhang BL . Comparison among families of Mutong . Zhongguo Zhong Yao Za Zhi . 2002;27:412–418 [In Chinese]
  92. Wu KM , Farrelly JG , Upton R , Chen J . Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development . Phytomedicine . 2006;
  93. Zhu YP . Toxicity of the Chinese herb mu tong (Aristolochia manshuriensis). What history tells us . Adverse Drug React Toxicol Rev . 2002;21:171–177

PII: S1561-5413(07)60003-9

doi:10.1016/S1561-5413(07)60003-9

Hong Kong Journal of Nephrology
Volume 9, Issue 1 , Pages 7-14, April 2007

Article Tools